One Year Later: Reflecting on Kyber Data Science Growth in the Forian Family

A year ago, Kyber Data Science joined Forian with a clear purpose: accelerate investors’ race to insights, as the only company singularly focused on supporting financial services customers with healthcare data. With new ability to access more and better data -- a key benefit of the Forian family -- and advancing our product portfolio for predictive power, it’s exciting to see how far we’ve come in just a year. What Forian enabled was the space, support, and scale for Kyber to become what clients experience today: the fastest route from healthcare hypotheses to investment intelligence conviction.

Real Time, Revenue-Focused Claims Intelligence 

Anyone can buy healthcare claims data. But claims alone, without a clean and stable infrastructure, historical backtesting for predictive accuracy, and scalable models for early forecasting can create more noise than insight.

Kyber reverses that. We give clients the full picture. 

We do the heavy lifting in three core areas: 

1. Data - We’re constantly evaluating new data sources, bringing the most useful or additive data sets to market, filling gaps in investors’ strategic portfolios.  
2. Analytic Tools - We’ve built hundreds of KPIs and machine learning models that surface meaningful signals earlier, providing high predictive accuracy and scalability by capitalizing on our ML-ready datasets. 
3. Interpretation - We take a supported partnership approach by sharing continuous healthcare data analyst observations, custom modeling, and expert interpretive guidance. 

Understanding the significance of investments being made, we also share the underlying drivers of our models in complete transparency. 

For investors, the Kyber client experience translates into a critical advantage: exponentially more time to act on these advantaged insights, across a greater universe of healthcare products. 

Let’s go deeper. 

True Impact of a ‘Data Intelligence System’

At its core, Kyber exists to help investors make better decisions with higher confidence. 

Understanding the potential -- and complexity -- of claims data and healthcare investment opportunities, Kyber built its data intelligence system to enable investors to:

• use and trust the data
• support ever-evolving and sophisticated models
• multiply the power of the healthcare analyst

Through backtesting and forecasting, investors can see how KPIs have behaved historically and how current patterns translate into quarterly revenue estimates. This transparency matters. It gives investors empirical grounding for conviction, rather than relying on intuition or isolated data points.

Earlier signals, paired with historical validation, allow investors to gain alpha as compared to peers without access to our data, insights, and intelligence system.

Healthcare Analytics Is All About Interpretation

Healthcare data is uniquely complex. Inventory stocking, patient assistance programs, payer mix shifts, specialty pharmacy distribution channels -- these dynamics need to be considered. We’ve built KPIs that surface these considerations and enrich investor models. 

Domain expertise is where Kyber’s client experience stands apart. Kyber clients get continuous guidance on interpretation, backed by the only data science team focused exclusively on healthcare for the Wall Street community.

This supported partnership approach reduces one of the biggest risks in data-driven investing: drawing the wrong conclusion because a key healthcare dynamic is overlooked. Kyber helps investors verify signals within the real-world mechanics of the healthcare system, ensuring insights reflect underlying fundamentals.

Earlier Insights Expand Investment Possibilities 

One of the most powerful outcomes of Kyber’s work over the past year has been making product-level revenue forecasts available as early as week six in the quarter, powered by machine-learning models in Kyber Focal Methods (KFM). With this earlier insight and clearer validation, investors can:

• Generate alpha well ahead of consensus
• Scale their forecasting across hundreds of products and tickers
• Test new hypotheses quickly

A System Built for Speed, Transparency, and Confidence

Underneath the surface, Kyber operates like an iceberg. What investors see -- KPIs, revenue forecasts, product launch insights -- is only a fraction of what exists below the waterline. Kyber has done all of the hard work to create a true data intelligence system that gives investors three durable advantages:

• Speed: A head start through early forecasting (week 6 in the quarter) leveraging ML-ready data and advanced modeling
• Transparency: Clear visibility into how signals have performed historically, and the underlying drivers of model performance
• Confidence: Interpretation and validation by healthcare experts with real-world context
  
  

One Year Stronger -- and Focused on What’s Next

One year after joining Forian, Kyber Data Science is farther ahead of investor needs than ever. The mission remains simple but powerful: help investors move faster, interpret signals correctly, and act with conviction in one of the most complex sectors in the market.

In a world where everyone has access to data, the winners will be those who trust it enough to act. That’s the advantage Kyber is building, and the value we continue to deliver to investors every day.